Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Oropharynx”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00003251
What this trial is testing

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerRadiation Toxicity
University of Illinois at Chicago 46
Testing effectiveness (Phase 2)Ended earlyNCT00017173
What this trial is testing

S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 13
Testing effectiveness (Phase 2)Study completedNCT00022594
What this trial is testing

Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 50
Not applicableEnded earlyNCT00898742
What this trial is testing

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01088802
What this trial is testing

Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx

Who this might be right for
Squamous Cell Carcinoma of Oropharynx
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Testing effectiveness (Phase 2)Looking for participantsNCT05307939
What this trial is testing

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Who this might be right for
HPVOropharynx CancerHPV-Related Carcinoma+2 more
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT02068157
What this trial is testing

Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous CarcinomaRecurrent Lip and Oral Cavity Squamous Cell Carcinoma+4 more
Roswell Park Cancer Institute 3
Not applicableLooking for participantsNCT06307327
What this trial is testing

Comparative Study of New Classification and Traditional Classification of Radioactive Oropharyngeal Mucositis

Who this might be right for
Head and Neck CancerRadiation-Induced Mucositis
Nanfang Hospital, Southern Medical University 264
Not applicableActive Not RecruitingNCT04151134
What this trial is testing

Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
Royal Marsden NHS Foundation Trust 100
Testing effectiveness (Phase 2)Looking for participantsNCT05799144
What this trial is testing

PBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer

Who this might be right for
Metastatic Oropharyngeal CarcinomaRecurrent Oropharyngeal Carcinoma
Michael K. Gibson 54
Not applicableStudy completedNCT03401840
What this trial is testing

STEREO-POSTOP 01 (PostOperative Hypofractionated Stereotactic Body Radiotherapy ) - GORTEC 2017-03

Who this might be right for
Head and Neck Neoplasms
Centre Jean Perrin 90
Testing effectiveness (Phase 2)Study completedNCT00030576
What this trial is testing

Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University Health Network, Toronto 51
Not applicableStudy completedNCT05025618
What this trial is testing

Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma (ARTOME)

Who this might be right for
Oropharynx Cancer
Center Eugene Marquis 132
Not applicableNot Yet RecruitingNCT07429890
What this trial is testing

REVIVE Prospective Registry Cohort Study

Who this might be right for
Oropharyngeal Dysphagia
University of California, Davis 31
Testing effectiveness (Phase 2)UnknownNCT04277858
What this trial is testing

Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.

Who this might be right for
Oropharynx CancerTonsil CancerThroat Cancer+1 more
Nader Sadeghi 60
Not applicableActive Not RecruitingNCT07407205
What this trial is testing

Tumor Mutational Burden, Liquid Biopsy, Angiogenic Factors and DCE-MRI Perfusion in HPV-Negative Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Squamous Cell CarcinomaOropharyngeal HPV Squamous Cell Carcinoma
Institute of Oncology Ljubljana 30
Not applicableStudy completedNCT02149602
What this trial is testing

A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck

Who this might be right for
Oropharyngeal Squamous Cell CancerHypopharyngeal Squamous Cell Cancer
Royal Marsden NHS Foundation Trust 120
Early research (Phase 1)Not Yet RecruitingNCT07832266
What this trial is testing

Proactively Intervening On Early Cranial Nerve Injury As A Delayed Sequela Of Oropharyngeal Cancer: A Randomized Feasibility Clinical Trial For Pro-Habilitation (proNERVE RCT)

Who this might be right for
Cranial Nerve InjuryOropharyngeal Cancer
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)UnknownNCT03669718
What this trial is testing

Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Who this might be right for
Squamous Cell Carcinoma of the OropharynxHPV16 Positive
ISA Pharmaceuticals 194
Not applicableLooking for participantsNCT06115772
What this trial is testing

Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study

Who this might be right for
Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma
Mayo Clinic 154
Next Page